Drugmakers may need indemnity for fast-tracked Ebola vaccines
A medical staff holds a package of an experimental candidate vaccine rVSV-ZEBOV against Ebola virus disease at the University hospital in Geneva October 22, 2014.
Credit: Reuters/Mathilde Missioneiro/WHO/Handout via Reuters
Read the original here:
Healthy Living News From around The Web
Drugmakers may need indemnity for fast-tracked Ebola vaccines – Reuters
4746 S. Broadway
Wichita, Ks 67216